STRONGBRIDGE BIOPHARMA plc (NASDAQ:SBBP) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders
On May15, 2018, Strongbridge Biopharma plc (the “Company”) held its Annual General Meeting of Shareholders (“AGM”) in Dublin,Ireland.Described below are the matters voted upon at the AGM and the number of votes for and against, abstentions and broker non-votes, as applicable.
Proposal No.1 — Re-election of ClassIII Directors – approved. Each of the ClassIII directors elected at the AGM will serve a three-year term until the conclusion of the Company’s 2021 annual general meeting and until such time as their successors are duly elected and qualified.
|
VotesFor |
VotesAgainst |
Abstain |
BrokerNon- Votes |
|
|
Matthew Pauls |
24,537,629 |
50,301 |
1,600 |
11,362,650 |
|
Garheng Kong |
22,577,554 |
2,009,376 |
2,600 |
11,362,650 |
Proposal No.2 — Ratification of Selection of Auditors and Authorization to Determine the Remuneration of the Auditors — approved. Shareholders were asked to vote to ratify the selection of Ernst& Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December31, 2018 and to authorize, in a binding vote, the board of directors, acting through its Audit Committee, to determine Ernst& Young’s remuneration.
|
Votes |
|
|
For |
35,937,590 |
|
Against |
11,768 |
|
Abstain |
2,822 |